The brain penetrant pan-PI3K inhibitor paxalisib targets PIK3CA and shows enhanced efficacy with radiotherapy, enzastaurin, and metformin in diffuse intrinsic pontine glioma. The gene discussed is PIK3CD; the disease is diffuse intrinsic pontine glioma.